Epidemiological studies of CHD and the evolution of preventive cardiology

[1]  G. Assmann,et al.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. , 1988, American heart journal.

[2]  Sc Prospective,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002 .

[3]  G. Thorgeirsson,et al.  Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study. , 1993, European heart journal.

[4]  A. Folsom,et al.  Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. , 2011, Journal of the American College of Cardiology.

[5]  Michael J. Pencina,et al.  Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.

[6]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[7]  Anita L. DeStefano,et al.  Evidence for a Gene Influencing Blood Pressure on Chromosome 17: Genome Scan Linkage Results for Longitudinal Blood Pressure Phenotypes in Subjects From the Framingham Heart Study , 2000, Hypertension.

[8]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[9]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[10]  A. Clarke,et al.  'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease. , 2012, The Cochrane database of systematic reviews.

[11]  D. Levy,et al.  Legacy of the framingham heart study: rationale, design, initial findings, and implications. , 2013, Global heart.

[12]  J. Chapman.  The Blood Pressure Lowering Treatment Trialists' Collaboration , 2001 .

[13]  Michael J Pencina,et al.  Genetic Predisposition to Higher Blood Pressure Increases Coronary Artery Disease Risk , 2013, Hypertension.

[14]  G. Thorgeirsson,et al.  Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik Study , 1995, Annals of Internal Medicine.

[15]  B. Howard,et al.  Diabetes and cardiovascular disease , 2000, Annual review of medicine.

[16]  Ralph L. Sacco,et al.  American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 Update: A Scientific Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers , 2013, Circulation.

[17]  J. Norris,et al.  Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart Study , 2003, BMC Genetics.

[18]  A. Keys,et al.  Seven countries. A multivariate analysis of death and coronary heart disease. , 1980 .

[19]  V. Gudnason,et al.  Coronary Artery Calcium, Brain Function and Structure: The AGES-Reykjavik Study , 2010, Stroke.

[20]  M. Biddle,et al.  A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.

[21]  Daniel W. Jones,et al.  Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. , 2005, Ethnicity & disease.

[22]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[23]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.

[24]  K L Ebi-Kryston,et al.  Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. , 1988, Journal of clinical epidemiology.

[25]  M. Budoff,et al.  Impact of Subclinical Atherosclerosis on Cardiovascular Disease Events in Individuals With Metabolic Syndrome and Diabetes , 2011, Diabetes Care.

[26]  S. Humphries,et al.  Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study , 2010, BMJ : British Medical Journal.

[27]  M. Marmot,et al.  Plasma cholesterol concentration and mortality. The Whitehall Study. , 1992, JAMA.

[28]  Lloyd E Chambless,et al.  Design and implementation of the Hispanic Community Health Study/Study of Latinos. , 2010, Annals of epidemiology.

[29]  B. Howard,et al.  Incidence of diabetes in American Indians of three geographic areas: the Strong Heart Study. , 2002, Diabetes care.

[30]  T. Dawber,et al.  II. Coronary Heart Disease in the Framingham Study , 1957 .

[31]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[32]  R A Kronmal,et al.  Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. , 1998, JAMA.

[33]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.

[34]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[35]  L. Chambless,et al.  Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. , 1991, American journal of epidemiology.

[36]  S B Hulley,et al.  CARDIA: study design, recruitment, and some characteristics of the examined subjects. , 1988, Journal of clinical epidemiology.

[37]  Zhimin Chen,et al.  Associations of Adiponectin and Leptin with Incident Coronary Heart Disease and Ischemic Stroke in African Americans: The Jackson Heart Study , 2013, Front. Public Health.

[38]  A. Folsom,et al.  Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[39]  Salim Yusuf,et al.  The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. , 2009, American heart journal.

[40]  G. Assmann,et al.  The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. , 1987, The American journal of cardiology.

[41]  Helmut Schulte,et al.  Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. , 2003, European heart journal.

[42]  C. Hennekens,et al.  A randomized trial of aspirin and β-carotene among U.S. physicians , 1985 .

[43]  P. Allhoff,et al.  The Oslo Study , 1991 .

[44]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[45]  苅尾 七臣,et al.  ガイドライン解説 AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease : 2011 update , 2012 .

[46]  N. Cook,et al.  Association Between 9 p 21 Genomic Markers and Heart Disease : A Meta-analysis , 2010 .

[47]  Nathan D. Wong,et al.  The Multiethnic Study of Atherosclerosis. , 2016, Global heart.

[48]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[49]  F. Tubach,et al.  Reclassification of European patients’ cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm , 2015, European journal of preventive cardiology.

[50]  Sholom Wacholder,et al.  Case–Control Study , 2005 .

[51]  G. Palomaki,et al.  Association between 9p21 genomic markers and heart disease: a meta-analysis. , 2010, JAMA.

[52]  F. Epstein.  Coronary Heart Disease Epidemiology Revisited: Clinical and Community Aspects , 1973, Circulation.

[53]  B. Norrving,et al.  Global atlas on cardiovascular disease prevention and control. , 2011 .

[54]  P. Greenland,et al.  Coronary artery calcium score and risk classification for coronary heart disease prediction. , 2010, JAMA.

[55]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.

[56]  J. Gardin,et al.  Racial differences in incident heart failure among young adults. , 2009, The New England journal of medicine.

[57]  A. Keys.  Atherosclerosis: a problem in newer public health. , 1953, Journal of the Mount Sinai Hospital, New York.

[58]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[59]  T. Pearson,et al.  Public policy approaches to the prevention of heart disease and stroke. , 2011, Circulation.

[60]  M. Szklo,et al.  The Multi-Ethnic Study of Atherosclerosis (MESA) , 2012 .

[61]  Jian Li,et al.  Physical Activity and Risk of Cardiovascular Disease—A Meta-Analysis of Prospective Cohort Studies , 2012, International journal of environmental research and public health.

[62]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[63]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[64]  V. Gudnason,et al.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. , 2007, American journal of epidemiology.

[65]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[66]  Daniel Levy,et al.  Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness , 2007, BMC Medical Genetics.

[67]  N. Lassen.  Epidemiologic assessment of the role of blood pressure in stroke. , 1996, JAMA.

[68]  C. Loria,et al.  Changes in risk factors for cardiovascular disease by baseline weight status in young adults who maintain or gain weight over 15 years: the CARDIA study , 2006, International Journal of Obesity.

[69]  Principal Investigators,et al.  The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .

[70]  Andrew D. Johnson,et al.  Genome-wide association study of blood pressure and hypertension , 2009, Nature Genetics.

[71]  Wei Li,et al.  Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study. , 2013, JAMA.

[72]  I. Holme,et al.  Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study. , 1980, Scandinavian journal of clinical and laboratory investigation.

[73]  S. Knutsen,et al.  The Tromsø Heart Study , 1989, Scandinavian journal of social medicine.

[74]  Vilmundur Gudnason,et al.  Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .

[75]  R. Kronmal,et al.  Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. , 2008, Journal of the American College of Cardiology.

[76]  Mark Woodward,et al.  Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies , 2012 .

[77]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[78]  Elisa T. Lee,et al.  The Strong Heart Study , 2015 .

[79]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[80]  Gower Street,et al.  Health inequalities among British civil servants: the Whitehall II study , 1991, The Lancet.

[81]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[82]  J. Manson,et al.  The Nurses' Health Study: 20-year contribution to the understanding of health among women. , 1997, Journal of women's health.

[83]  S. Yusuf,et al.  Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[84]  T. Dawber,et al.  Coronary heart disease in the Framingham study. , 1957, American journal of public health and the nation's health.

[85]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.

[86]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[87]  F. Epstein.  Cardiovascular disease epidemiology: a journey from the past into the future. , 1996, Circulation.

[88]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[89]  L H Kuller,et al.  Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. , 1992 .

[90]  H. Keen,et al.  Myocardial ischaemia, risk factors and death from coronary heart-disease. , 1977, Lancet.

[91]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[92]  E. Simonson,et al.  Coronary Heart Disease among Minnesota Business and Professional Men Followed Fifteen Years , 1963, Circulation.

[93]  Alan D. Lopez,et al.  Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[94]  R. Collins,et al.  Statins for people at low risk of cardiovascular disease – Authors' reply , 2012, The Lancet.

[95]  W. Kannel,et al.  A general cardiovascular risk profile: the Framingham Study. , 1976, The American journal of cardiology.

[96]  R. Detrano,et al.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2005, Radiology.

[97]  Michael J. Pencina,et al.  Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study , 2006, Circulation.

[98]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations , 1999, The Lancet.

[99]  A. Clarke,et al.  Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases. , 2012, The Cochrane database of systematic reviews.

[100]  V. Preedy,et al.  National Health and Nutrition Examination Survey , 2010 .

[101]  Mark Woodward,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. , 2011, Lancet.

[102]  C. Lewis,et al.  The CARDIA Study , 2009 .

[103]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.

[104]  S. Syme,et al.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. , 1975, American journal of epidemiology.

[105]  J. Polak,et al.  Age‐Related Trends in Cardiovascular Morbidity and Physical Functioning in the Elderly: The Cardiovascular Health Study , 1993, Journal of the American Geriatrics Society.

[106]  W. Kannel,et al.  Cigarette Smoking and Coronary Heart Disease , 1962 .

[107]  R. Detrano,et al.  Ethnic Differences in Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2005, Circulation.

[108]  S A Stansfeld,et al.  Low job control and risk of coronary heart disease in whitehall ii (prospective cohort) study , 1997, BMJ.

[109]  Eric Boerwinkle,et al.  Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. , 2010, Journal of the American College of Cardiology.

[110]  P. Savage,et al.  The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. , 1990, American journal of epidemiology.

[111]  J. Danesh,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.

[112]  H. Keen,et al.  MYOCARDIAL ISCHÆMIA, RISK FACTORS AND DEATH FROM CORONARY HEART-DISEASE , 1977, The Lancet.

[113]  W. Kannel,et al.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.

[114]  P. Wolf,et al.  Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. , 1970, JAMA.

[115]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[116]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[117]  B. Howard,et al.  Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. , 2003, Diabetes care.

[118]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[119]  L. Pilotto.  [Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[120]  Bernard J. Gersh,et al.  Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention , 2007, Circulation.

[121]  C. Roy.  From the Past into the Future , 2016 .

[122]  D. Goff,et al.  Erratum: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (J Am Coll Cardiol (2013) DOI:10.1016/j.jacc.2013.11.005) , 2014 .

[123]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.

[124]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[125]  D. Cook,et al.  SOCIAL CLASS DIFFERENCES IN ISCHAEMIC HEART DISEASE IN BRITISH MEN , 1987, The Lancet.

[126]  H. Tunstall-Pedoe,et al.  Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations , 2000, The Lancet.

[127]  M. Burtscher.  Lifetime risks of cardiovascular disease. , 2012, The New England journal of medicine.

[128]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[129]  M. Marcelli,et al.  Design and Methods , 2011 .

[130]  S. Yusuf,et al.  Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey , 2011, The Lancet.

[131]  A. Folsom,et al.  Prevalence and Correlates of Coronary Calcification in Black and White Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[132]  A. Hardy,et al.  Mortality , 1953, The Panama Railroad.

[133]  F. Schmidt.  Meta-Analysis , 2008 .

[134]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[135]  H. S. Klopfenstein,et al.  Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[136]  Sixty Years of Preventive Cardiology: A Framingham Perspective , 2011, Clinical cardiology.

[137]  P. Allhoff,et al.  The Stockholm Prospective Study , 1991 .

[138]  R. Luepker.  WHO MONICA Project: What Have We Learned and Where to Go from Here? , 2011 .

[139]  J. Sowers,et al.  Diabetes and cardiovascular disease. , 1999, Diabetes care.

[140]  V. Gudnason,et al.  Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study , 2011, BMJ Open.

[141]  E. Barrett-Connor,et al.  Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. , 1983, American journal of epidemiology.

[142]  N. Schneiderman,et al.  Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. , 2012, JAMA.

[143]  J. Gallacher,et al.  Lipid-related markers and cardiovascular disease prediction. , 2012, JAMA.

[144]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[145]  I. Rogers,et al.  Breast feeding: benefits and hazards. Methodology and summary of results. , 1997, Early human development.

[146]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[147]  C. Jenkins,et al.  Coronary heart disease in the Western collaborative group study. A follow-up experience of two years. , 1966, JAMA.

[148]  Roberto Ferrari,et al.  Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). , 2012, Journal of the American College of Cardiology.

[149]  C. Hennekens,et al.  A randomized trial of aspirin and beta-carotene among U.S. physicians. , 1985, Preventive medicine.

[150]  F. Turnbull.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[151]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[152]  A. Dobson,et al.  Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations , 2000, The Lancet.

[153]  R. Brand,et al.  The relationship of reported parental history to the incidence of coronary heart disease in the Western Collaborative Group Study. , 1970, American journal of epidemiology.

[154]  R. Califf,et al.  27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. , 1996, Journal of the American College of Cardiology.

[155]  W. Brown.  Framingham Heart Study. , 2011, Journal of clinical lipidology.

[156]  Enrique Sanchez-Delgado,et al.  Lifetime risk of developing coronary heart disease , 1999, The Lancet.

[157]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[158]  S. Lindstedt,et al.  The Stockholm prospective study. 1. The initial values for plasma lipids. , 1968, Acta medica Scandinavica. Supplementum.

[159]  J. Gallacher,et al.  C-reactive protein, fibrinogen, and cardiovascular disease prediction. , 2012, The New England journal of medicine.

[160]  H. Hense,et al.  Trends in coronary risk factors in the WHO MONICA project. , 2001, International journal of epidemiology.

[161]  J C Christian,et al.  The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. , 1977, American journal of epidemiology.

[162]  Martin J Shipley,et al.  Justice at work and reduced risk of coronary heart disease among employees: the Whitehall II Study. , 2005, Archives of internal medicine.

[163]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[164]  L. Kuller,et al.  A “natural experiment” in cardiovascular epidemiology in the early 21st century , 2003, Heart.

[165]  Xi-gui Wu,et al.  A north‐south comparison of blood pressure and factors related to blood pressure in the People's Republic of China: a report from the PRC‐USA Collaborative Study of Cardiovascular Epidemiology , 1994, Journal of hypertension.

[166]  C. Fox,et al.  Pericardial Adipose Tissue, Atherosclerosis, and Cardiovascular Disease Risk Factors: The Jackson Heart Study , 2010, Diabetes Care.

[167]  D. Goff,et al.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.

[168]  E. Boerwinkle,et al.  The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. , 2010, Atherosclerosis.

[169]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[170]  Roberto Ferrari,et al.  Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). , 2012, Circulation.

[171]  M. Jokela,et al.  The Whitehall II Study , 2009 .